Sat Kartar Life Limited (NSEI: SATKARTAR)
Health Care · Pharmaceuticals · IN
Rs121.00
-2.34% today · -30.4% 1Y
Sat Kartar Life Limited (NSEI: SATKARTAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $19.92M.
Over the last twelve months the share price has lost 30.4%, trading between 116.25 and 219.80.
Tweenvest scores Sat Kartar Life Limited across four factors: quality 67/100, value 90/100, growth 100/100, dividend 9/100. Its strongest factor is growth.
SATKARTAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.92M
- Revenue (TTM)
- $21.40M
- P/E
- 11.14
- EPS
- 10.86
- Dividend yield
- 0.58%
- Beta (5Y)
- —
- 52-week high
- Rs219.80
- 52-week low
- Rs116.25
- Avg volume (3M)
- —
- Shares outstanding
- 15.74M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,237.51 | -1.43% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.29 | +0.76% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.48 | -1.36% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.89 | -0.64% |
Figures last refreshed Aug 18, 2026.